Will the Headache Field Embrace Rofecoxib (Vioxx)?

Experts discuss the history of rofecoxib, including its market withdrawal and subsequent resurrection. The once-bestselling painkiller known as Vioxx is now proceeding to a phase 3 trial for migraine.
Medscape Medical News